Generate Biomedicines, Inc. (GENB)
17.72
+1.60
(+9.93%)
USD |
NASDAQ |
Aug 24, 16:00
17.62
-0.10
(-0.56%)
After-Hours: 20:00
Generate Biomedicines Total Liabilities (Quarterly) : 105.64M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 105.64M |
| Date | Value |
|---|---|
| March 31, 2026 | 110.94M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Twist Bioscience Corp. | 226.70M |
| Prime Medicine, Inc. | 209.23M |
| Intellia Therapeutics, Inc. | 129.46M |
| Beam Therapeutics, Inc. | 318.91M |
| Moderna, Inc. | 4.20B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 561.69M |
| Shareholders Equity (Quarterly) | 456.04M |
| Debt to Equity Ratio | 0.1373 |
| Current Ratio | 8.303 |
| Net Debt Paydown Yield | -0.47% |